Clonal origin of lineage switch leukemia following CAR-T cell and blinatumomab therapy
Clonal origin of lineage switch leukemia following CAR-T cell and blinatumomab therapy
- 04/08/2022
- 8 samples
- DAC: EGAC00001000205
- Technology: Illumina NovaSeq 6000
Wellcome Trust Sanger Institute Data Sharing Policy
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001006486 | Whole Genome Sequencing |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF00006702130 | 1659616221019 | 70.5 GB |
|
|
| EGAF00006702131 | 1659615321019 | 67.2 GB |
|
|
| EGAF00006702132 | 1659615321019 | 73.8 GB |
|
|
| EGAF00006702133 | 1659616221019 | 67.3 GB |
|
|
| EGAF00006702134 | 1659614421023 | 61.2 GB |
|
|
| EGAF00006702135 | 1659616221019 | 79.5 GB |
|
|
| EGAF00006702136 | 1659615321019 | 60.4 GB |
|
|
| EGAF00006702137 | 1659615321019 | 71.5 GB |
|
|
| 8 Files (551.5 GB) | ||||